Trial Profile
A comparison of the efficacy beyond 48 hours of insulin aspart (Novolog) and lispro (Humalog) in insulin pumps
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 10 Nov 2021
Price :
$35
*
At a glance
- Drugs Insulin aspart (Primary) ; Insulin lispro (Primary)
- Indications Type 1 diabetes mellitus
- Focus Therapeutic Use
- 10 May 2010 Status changed from active, no longer recruiting to completed.
- 01 Apr 2010 Results published in the Journal of Diabetes and its Complications
- 01 Apr 2010 Status change from active, no longer recruiting to completed